Busulfan analysis with quantitative UPLC-MS/MS for clinical research

Achieve rapid analysis and increased sensitivity

Traditional analytical methods encounter challenges when quantifying busulfan, an antineoplastic cancer therapy, due to its bioavailability. UPLC-MS/MS analysis with the ACQUITY UPLC I-Class PLUS and Xevo TQD Mass Spectrometer provides clinical research laboratories with highly selective and accurate data, as well as and rapid analysis and increased sensitivity.

产品 | 价格
  • 概要
  • 相关信息
  • 应用文章
`
返回顶部 返回顶部